Lexicon Pharmaceuticals (LXRX) Operating Expenses (2010 - 2026)
Lexicon Pharmaceuticals (LXRX) posted quarterly Operating Expenses of $22.1 million for Q1 2026, down 17.98% year-over-year from $26.9 million in Q1 2025, and up 9.0% quarter-over-quarter from $20.3 million in Q4 2025.
Lexicon Pharmaceuticals (LXRX) Operating Expenses (2010 - 2026) Analysis & Trends
Lexicon Pharmaceuticals (LXRX) has reported Operating Expenses for 17 consecutive years, with $22.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Expenses fell 17.98% year-over-year to $22.1 million; the TTM figure through Mar 2026 stood at $93.9 million (down 55.02% YoY), while the FY2025 annual figure was $98.7 million, down 56.74% from the prior year.
- Operating Expenses rose to $22.1 million in Q1 2026 per LXRX's latest filing, from $20.3 million in the prior quarter.
- Across five years, Operating Expenses topped out at $65.4 million in Q3 2024 and bottomed at $20.3 million in Q4 2025.
- Historically, Operating Expenses has averaged $36.6 million across 5 years, with a median of $30.3 million in 2022.
- Annual changes were most pronounced in 2023 — Operating Expenses surged 115.24% — and 2025, when it plunged 65.81%.
- Lexicon Pharmaceuticals' Operating Expenses stood at $30.3 million in 2022, then jumped by 56.53% to $47.4 million in 2023, then grew by 24.98% to $59.3 million in 2024, then slumped by 65.81% to $20.3 million in 2025, then climbed by 9.0% to $22.1 million in 2026.
- Business Quant data shows LXRX's Operating Expenses at $22.1 million in Q1 2026, $20.3 million in Q4 2025, and $26.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Lexicon Pharmaceuticals | 1.04 Bn | 846.13 Mn | 653,000.00 | 27.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 27.23 Mn |
| Mar 31, 2026 | 22.10 Mn |
| Dec 31, 2025 | 20.27 Mn |
| Sep 30, 2025 | 26.37 Mn |
| Jun 30, 2025 | 25.13 Mn |
| Mar 31, 2025 | 26.94 Mn |
| Dec 31, 2024 | 59.29 Mn |
| Sep 30, 2024 | 65.44 Mn |
| Jun 30, 2024 | 57.00 Mn |
| Mar 31, 2024 | 46.46 Mn |
| Dec 31, 2023 | 47.44 Mn |
| Sep 30, 2023 | 49.79 Mn |
| Jun 30, 2023 | 44.56 Mn |
| Mar 31, 2023 | 31.17 Mn |
| Dec 31, 2022 | 30.31 Mn |
| Sep 30, 2022 | 23.13 Mn |
| Jun 30, 2022 | 24.04 Mn |
| Mar 31, 2022 | 23.42 Mn |
| Dec 31, 2021 | 25.34 Mn |
| Sep 30, 2021 | 22.99 Mn |